Lexaria Bioscience Corp. (LEXX)
11.66
+1.12
(+10.58%)
USD |
NASDAQ |
Aug 25, 16:00
11.66
0.00 (0.00%)
After-Hours: 16:09
Lexaria Bioscience Total Liabilities (Quarterly) : 0.4371M for May 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| May 31, 2026 | 0.4371M |
| February 28, 2026 | 0.277M |
| November 30, 2025 | 1.527M |
| August 31, 2025 | 1.572M |
| May 31, 2025 | 1.575M |
| February 28, 2025 | 1.917M |
| November 30, 2024 | 0.3997M |
| August 31, 2024 | 1.209M |
| May 31, 2024 | 0.2714M |
| February 29, 2024 | 0.2042M |
| November 30, 2023 | 0.254M |
| August 31, 2023 | |
| May 31, 2023 | 1.198M |
| February 28, 2023 | 0.2231M |
| November 30, 2022 | 0.2815M |
| August 31, 2022 | 0.2014M |
| May 31, 2022 | 0.2252M |
| February 28, 2022 | 0.1946M |
| November 30, 2021 | 0.2773M |
| August 31, 2021 | 0.2033M |
| May 31, 2021 | 0.2814M |
| February 28, 2021 | 0.4695M |
| November 30, 2020 | 0.3533M |
| August 31, 2020 | 0.346M |
| May 31, 2020 | 0.1197M |
| Date | Value |
|---|---|
| February 29, 2020 | 0.0633M |
| November 30, 2019 | 0.1302M |
| August 31, 2019 | 0.1845M |
| May 31, 2019 | 0.1323M |
| February 28, 2019 | 0.5001M |
| November 30, 2018 | 0.1299M |
| August 31, 2018 | 0.0436M |
| May 31, 2018 | 0.0716M |
| February 28, 2018 | 0.069M |
| November 30, 2017 | 0.0957M |
| August 31, 2017 | 0.0923M |
| May 31, 2017 | 0.085M |
| February 28, 2017 | 0.3785M |
| November 30, 2016 | 0.5135M |
| August 31, 2016 | 0.4789M |
| May 31, 2016 | 0.3765M |
| February 29, 2016 | 0.2843M |
| November 30, 2015 | 0.1774M |
| August 31, 2015 | 0.0551M |
| May 31, 2015 | 0.0626M |
| February 28, 2015 | 0.0381M |
| November 30, 2014 | 0.7894M |
| October 31, 2014 | |
| July 31, 2014 | 1.017M |
| April 30, 2014 | 1.105M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Target Group, Inc. (Canada) | 14.33M |
| InMed Pharmaceuticals, Inc. | 2.242M |
| NervGen Pharma Corp. | 51.39M |
| Milestone Pharmaceuticals, Inc. | 163.41M |
| Clearmind Medicine, Inc. | 3.033M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 4.781M |
| Shareholders Equity (Quarterly) | 4.738M |
| Debt to Equity Ratio | 0.0183 |
| Current Ratio | 10.60 |
| Net Debt Paydown Yield | 0.05% |